High Tide Inc. (HITI)
Healthcare
- Fundamental
- 3
- Sentiment
- 3
- Technical
- 3
Do Nothing: avgDollarVolume20 ~$2.62M is below the $5M 20-day average dollar-volume floor - neither entry type qualifies: a pullback limit into the 2.505-2.52 support shelf and a breakout buy-stop above the 2.73-2.78 shelf are both barred by the floor, and the breakout entry also fails R/R (0.70-0.98 < 1.0) against the 2.505 swing low.
Company overview
High Tide Inc. is a cannabis retailer with operations in Canada, Europe, the U.S., and other international markets. The company designs, manufactures, and distributes smoking accessories and cannabis lifestyle products through wholesale and direct-to-consumer channels. It also offers data analytics services and manages e-commerce platforms Grasscity.com and CBDcity.com.
Fundamental
fairHigh Tide shows strong growth and cash generation, but faces elevated leverage and regulatory risks.
Mixed fundamentals: strong revenue growth (about 35% five-year CAGR), record adjusted EBITDA, positive free cash flow, a leading Canadian retail position and a fast-growing German medical business — offset by elevated leverage, trailing GAAP losses driven by non-cash impairments, thin trailing interest coverage, and meaningful U.S. cannabis regulatory risk. Watchlist-quality rather than a high-conviction buy.
Sentiment
fairSentiment is mildly positive with thin retail engagement and no immediate catalysts.
Dominant backdrop is digestion of the Sep 14 record Q3 print (announced confidence; trailing beyond 14 days and partially priced) with no forward-dated catalyst inside 30 days; the sentiment delta is determinate and flat (baseline ~ +0.17 to scoring ~ +0.07 broad / +0.20 primary). In-window signals conflict - a Wall Street Zen Hold downgrade and a +78.2% short-interest build (mild bearish) against an Oct 6 +4.55% momentum session on record-results read-through (bullish, rumored) - so a moderate red-flag cap applies (conflicting catalysts; ceiling 3). Red-Flag Screen: no severe flags.
Technical
fairThe stock is in a pullback within a longer uptrend, with no confirmed bullish setup due to liquidity constraints.
Mixed 3/5 read, negative-tilted near term: longer-term structure is constructive (price above the rising SMA50 2.52 and SMA200 2.43; higher swing lows since July), but the near-term tape is weak - a failed push at 2.85, a -5.49% session closing below the 2.60 range floor and below the entire short-term average stack (SMA20/EMA9/EMA21/WMA9/WMA21/DEMA14/TEMA14), RSI14 46.2 fading, MACD histogram -0.02. No confirmed bullish setup is present, and the trade is additionally barred by liquidity: avgDollarVolume20 ~$2.62M < $5M floor, so no entry is admissible.
You’re looking at 2026-10-09 — more than 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Healthcare
Not financial advice. For informational and educational purposes only.

